Rare Side Effect Of AstraZeneca's Covishield Explained
Image: ANI
1 May 2024
AstraZeneca's COVID-19 vaccine has been linked to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS)
Image: ANI
This acknowledgement follows a lawsuit filed against the company, alleging serious harm and deaths linked to the vaccine
Image: ANI
Covishield, a vaccine developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India, can, in rare instances, lead to this condition
Image: ANI
This vaccine was extensively administered throughout India during the Covid-19 pandemic
Image: ANI
Thrombosis with Thrombocytopenia Syndrome (TTS) is a rare condition in which blood clots form in unusual places in the body, and the number of platelets in the blood drops
Image: ANI
Platelets are small cells that help blood to clot, so having too few of them can be dangerous
Image: ANI
The condition was observed in people who received adenoviral vector COVID-19 vaccines, such as Vaxzevria, Covishield (AstraZeneca) and the Johnson & Johnson/Janssen COVID-19 vaccine
Image: ANI
TTS seems to occur because the body's immune system reacts to the vaccine by making antibodies that attack a protein involved in blood clotting
Image: ANI
TTS is classified into 2 tiers by the CDC
Image: ANI
Check More Stories
Image: ANI
ndtv.com